Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-12-008173
Filing Date
2012-08-10
Accepted
2012-08-10 13:15:24
Documents
11
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q gfr_10q-063012.htm 10-Q 783434
2 EXHIBIT 31.1 ex31-1.htm EX-31.1 19005
3 EXHIBIT 31.2 ex31-2.htm EX-31.2 19540
4 EXHIBIT 32.1 ex32-1.htm EX-32.1 5653
5 EXHIBIT 32.2 ex32-2.htm EX-32.2 5670
  Complete submission text file 0001437749-12-008173.txt   5813601

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE gfrp-20120630.xml EX-101.INS 1187867
7 XBRL TAXONOMY EXTENSION SCHEMA gfrp-20120630.xsd EX-101.SCH 40908
8 XBRL TAXONOMY EXTENSION CALCULATION gfrp-20120630_cal.xml EX-101.CAL 28610
9 XBRL TAXONOMY EXTENSION DEFINITION gfrp-20120630_def.xml EX-101.DEF 197765
10 XBRL TAXONOMY EXTENSION LABELS gfrp-20120630_lab.xml EX-101.LAB 235294
11 XBRL TAXONOMY EXTENSION PRESENTATION gfrp-20120630_pre.xml EX-101.PRE 202052
Mailing Address 9160 E. DEER TRAIL 9160 E. DEER TRAIL TUCSAN AZ 85710
Business Address SUITE 11405 - 201A STREET MAPLE RIDGE A1 V2X 0Y3 5205771516
GFR PHARMACEUTICALS INC (Filer) CIK: 0001096294 (see all company filings)

EIN.: 770517964 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-27959 | Film No.: 121023770
SIC: 2834 Pharmaceutical Preparations